Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
151.70
+0.70 (0.46%)
At close: Dec 4, 2025

Jamjoom Pharmaceuticals Factory Company Company Description

Jamjoom Pharmaceuticals Factory Company, together with its subsidiaries, engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

The company offers human medicines; nutraceuticals; antibiotics; general analgesics; medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, and ulcer and acidity; treatment of various skin infections and cancer diseases; and eye drops, and ointments and cosmeceuticals.

It also provides ophthalmic solutions, dermatology products, cardiovascular health, consumer health, respiratory health, gastrointestinal health, endocrinology and diabetes care, central nervous system, and pain and inflammation pharmaceutical products.

Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.

Jamjoom Pharmaceuticals Factory Company
Country Saudi Arabia
Founded 1994
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO Tarek Youssef Hosni

Contact Details

Address:
Corniche Road
Jeddah, 21442
Saudi Arabia
Phone 966 12 614 0099
Website jamjoompharma.com

Stock Details

Ticker Symbol 4015
Exchange Saudi Stock Exchange
Fiscal Year January - December
Reporting Currency SAR
ISIN Number SA15QGU1UNH6
SIC Code 2834

Key Executives

Name Position
Tarek Youssef Hosni Chief Executive Officer
Anwer Muhiddein Chief Financial Officer
Mohammed Jamjoom Chief Operating Officer
Hussam Salousa Head of Investor Relations